Table 4.
Baseline characteristics of paediatric Crohn’s disease patients [n = 30]. Data presented as mean [SD] or median [Q1-Q3] unless stated otherwise
Characteristics | Values |
---|---|
Age, years | 12.2 [2.4] |
Female, n [%] | 11/30 [37%] |
Body weight, kg | 43.6 [14.5] |
Body weight z-score, SD | 0.10 [1.09] |
Height z-score, SD | 0.27 [1.07] |
BMI z-score, SD | -0.20 [-0.89–0.24] |
wPCDAI | 2.5 [0.0–10.6] |
CRP, mg/L | 1.0 [1–5.3] |
Raised CRP [>10 mg/L], n [%] | 1/30 [3%] |
FC, mg/kg | 328.3 [154.2–2369.9] |
Raised FC [>250 mg/kg], n [%] | 17/30 [57%] |
Newly diagnosed patients, n [%] | 23/30 [77%] |
Immunosuppressant use, n [%] | 17/30 [57%] |
Paris classification: | |
Age at diagnosis, n [%] | |
A1a | 8/30 [27%] |
A1b | 22/30 [73%] |
Location, n [%] | |
L1 | 2/30 [7%] |
L1, L4a | 2/30 [7%] |
L1, L4b | 1/30 [3%] |
L2 | 3/30 [10%] |
L2, L4a | 2/30 [7%] |
L3 | 9/30 [30%] |
L3, L4a | 6/30 [20%] |
L4a | 5/30 [17%] |
Behaviour, n [%] | |
B1 | 27/30 [90%] |
B1p | 2/30 [7%] |
B2 | 1/30 [3%] |
Growth, n [%] | |
G1 | 2/30 [7%] |
G0 | 28/30 [93%] |
BMI, body mass index; CRP, C-reactive protein; FC, faecal calprotectin; wPCDAI: weighted Paediatric Crohn’s Disease Activity Index.